| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997032570A1 Implants with phased release of medicaments |
| 09/12/1997 | WO1997032566A1 Cosmetic composition including an aqueous dispersion of polymeric particles, and use thereof |
| 09/12/1997 | WO1997028104A3 Buffer systems for use in stabilizing pharmaceutical preparations |
| 09/12/1997 | WO1997017946A3 Method and device for producing a parenteral medicament |
| 09/12/1997 | CA2244894A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | CA2198922A1 Compound thickened with a polysaccharide alkyl ether |
| 09/11/1997 | DE19608423A1 Implantate mit phasenweiser Arzneistoffabgabe Implants with phased drug delivery |
| 09/11/1997 | DE19608012A1 Stabilisation of super-saturated medicinal solutions by crystallisation inhibitors |
| 09/11/1997 | CA2199640A1 Finely dispersed carotenoid and retinoid suspensions and their preparation |
| 09/11/1997 | CA2199415A1 Stable aqueous solubilizates of carotenoids and vitamins |
| 09/11/1997 | CA2199414A1 Stable carotenoid emulsions suitable for parenteral administration |
| 09/10/1997 | EP0794211A2 Blends containing absorbable polyoxaamides |
| 09/10/1997 | EP0794208A2 Absorbable polyoxaesters |
| 09/10/1997 | EP0793972A2 Adhesive percutaneous preparation |
| 09/10/1997 | EP0793966A1 Cyclosporin-containing topical pharmaceutical composition |
| 09/10/1997 | EP0793965A2 Prophylactic/therapeutic composition for secondary cataract |
| 09/10/1997 | EP0793963A1 Percutaneously administrable preparation |
| 09/10/1997 | EP0793959A1 Controlled-release composition |
| 09/10/1997 | EP0793958A2 Process for preparing a composition containing fenofibrate |
| 09/10/1997 | EP0793957A1 Cosmetic composition comprising an aqueous dispersion of polymeric particles and use thereof |
| 09/10/1997 | EP0793517A1 Composition and method for enhancing electrotransport agent delivery |
| 09/10/1997 | EP0793495A1 Freeze-dried ondansetron compositions |
| 09/10/1997 | EP0793485A1 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| 09/10/1997 | EP0793484A1 Adjuvant for a vaccine composition |
| 09/10/1997 | EP0793483A1 Methods of treating lung disease |
| 09/10/1997 | EP0769996A4 Method and apparatus for retaining a formed compression dosage unit within a die cavity |
| 09/10/1997 | EP0734249A4 Novel and improved aminoglycoside formulation for aerosolization |
| 09/10/1997 | EP0705125B1 Drying water-containing valuable substances or mixtures thereof with superheated steam |
| 09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/10/1997 | EP0664701B1 Taste-masking compositions of ranitidine |
| 09/10/1997 | EP0644757B1 Pharmaceutical compositions containing nsaid and bile acids |
| 09/10/1997 | EP0625046B1 Pharmaceutical aerosol formulations comprising beclomethasone dipropionate |
| 09/10/1997 | EP0617612B1 A process for the preparation of a solid dispersion |
| 09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
| 09/10/1997 | CN1158742A Soluble granule containing ginkgo leaf extract (EGb) |
| 09/10/1997 | CN1158738A Nasosinusitis capsule |
| 09/10/1997 | CN1158737A Baged medicine for diabetes and its preparation |
| 09/10/1997 | CN1158734A Cigariete-type medicine for curing tracheitis and asthma and its production process |
| 09/10/1997 | CN1158733A Preparation of external-use ointment for burn and scald |
| 09/10/1997 | CN1158730A Chewing gum with Radix isatidis and its prepn process |
| 09/10/1997 | CN1158729A Medicine powder for hepatitis B and its prepn |
| 09/10/1997 | CN1158726A Process for making pharmaceutical formulation containing novel steroid esters |
| 09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
| 09/09/1997 | US5665879 Amphiphilic derivatives of piperazine |
| 09/09/1997 | US5665782 Hydrolyzed gelatin as a flavor enhancer in a chewable table |
| 09/09/1997 | US5665773 Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension |
| 09/09/1997 | US5665770 Particles carrying a disulfide or reducing thiol |
| 09/09/1997 | US5665766 Ester of an organic nitrate and a salicylate |
| 09/09/1997 | US5665760 Lyophilized thioxanthenone antitumor agents |
| 09/09/1997 | US5665711 Antitumor composition for oral administration |
| 09/09/1997 | US5665710 Method of making liposomal oligodeoxynucleotide compositions |
| 09/09/1997 | US5665700 Pharmaceutical formulations |
| 09/09/1997 | US5665561 Administering one or more carbohydrate entities, such as a disaccharide with an n-acetyl-d-glucosamine motif |
| 09/09/1997 | US5665428 Preparation of peptide containing biodegradable microspheres by melt process |
| 09/09/1997 | US5665414 Cellulosic materials for incorporation into food products and methods of making same |
| 09/09/1997 | US5665394 Matrix for sustained-release preparation |
| 09/09/1997 | US5665393 Herbal composition for treating prostate carcinoma |
| 09/09/1997 | US5665392 Administering anemonin pretensis powder and quinine sulfate mixture; side effect reduction |
| 09/09/1997 | US5665390 Sustituted 3,5-diene steroidal compounds |
| 09/09/1997 | US5665389 Insulin, vibrio cholera zonula occludens toxin |
| 09/09/1997 | US5665388 Method for preparation of an alkaline and aspirin combination compound |
| 09/09/1997 | US5665381 Inhibition of aggregation of drug containing particles |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665379 Lipid particle forming matrix, preparation and use thereof |
| 09/09/1997 | US5665378 Transdermal therapeutic formulation |
| 09/09/1997 | US5665377 Administration system for estradiol |
| 09/09/1997 | US5665376 Method for reducing excessive stomach acid |
| 09/09/1997 | US5665373 Prostaglandins, thromboxanes and leukotriene healing agents |
| 09/09/1997 | US5665363 Inoculation of animals with dried, pelleted biological materials |
| 09/09/1997 | US5665332 Propellantless dispenser for dentifrices, gargles, mouthwashes |
| 09/09/1997 | US5665331 Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
| 09/07/1997 | CA2199345A1 Controlled-release composition |
| 09/05/1997 | CA2199079A1 Blends of absorbable polyoxaamides |
| 09/05/1997 | CA2198989A1 Absorbable polyoxaesters |
| 09/04/1997 | WO1997032046A1 Method and composition for hair removal |
| 09/04/1997 | WO1997031938A1 Oligopeptides for drug delivery |
| 09/04/1997 | WO1997031935A1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/04/1997 | WO1997031927A1 Tetraether lipids and liposomes containing said lipids, and use of the same |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031747A1 Laser drilling process for producing a plurality of holes in chemical dosage forms using acousto-optic deflector |
| 09/04/1997 | WO1997031691A1 Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
| 09/04/1997 | WO1997031658A1 Ophthalmologically useful composition, products containing the composition and process for disinfecting and/or cleaning contact lenses |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031649A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON |
| 09/04/1997 | WO1997031639A1 TABLETS CONTAINING β-LACTAM ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME |
| 09/04/1997 | WO1997031627A1 Use of microcrystalline starch products as tabletting excipient |
| 09/04/1997 | WO1997031626A1 Powdery composition for nasal administration |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | WO1997031624A1 Liposomal delivery system |
| 09/04/1997 | WO1997031623A1 Non-aqueous controlled release pest and air care gel composition |
| 09/04/1997 | WO1997031621A1 Delivery system for localized administration of medicaments to the upper respiratory tract |
| 09/04/1997 | WO1997020582A3 Transdermal patch for comparative evaluations |
| 09/04/1997 | DE19608137A1 Improved diatetics or transport media for actives incorporated in liposomes |
| 09/04/1997 | DE19607722A1 Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung Tetraether and these liposomes containing them and their use |
| 09/04/1997 | DE19605548A1 Zusammensetzung für die Transfektion höherer eukaryotischer Zellen Composition for the transfection of higher eukaryotic cells |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2247048A1 Oligopeptides for drug delivery |
| 09/03/1997 | EP0792644A1 Aqueous eye drops containing apafant as principal agent |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |